Comparing two liver scanners for people with chronic liver disease
Part of Digestive system, Infections clinical trials.
This study compares two types of liver scanners that measure liver stiffness (a sign of scarring) to see if a new handheld device works as well as the standard one. If the devices are similar, it may allow easier and more affordable liver monitoring for people with chronic liver disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years of age or older.
- You must have one of these conditions: chronic hepatitis B (with or without cirrhosis) or fatty liver disease (called MAFLD or MASH) that may cause liver scarring.
- You must be able to sit in a certain position and have no unhealed wounds on your upper right belly area.
- You must not have other causes of liver disease, such as hepatitis C, autoimmune hepatitis, or alcohol-related liver damage.
- You must not have serious liver complications, liver cancer, large liver cysts, or be pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new wearable patch that uses ultrasound to measure liver stiffness without needing a permanent probe. It could be a more comfortable and convenient way to check your liver health, and results will be compared to the standard FibroScan test.
This study uses a special ultrasound device called iLivTouch to measure liver stiffness. It aims to see if changes in liver stiffness over time can predict serious liver problems in people with metabolic fatty liver disease. If you have MAFLD and your liver is already stiff, this could help doctors monitor your condition.
This study tests a new way to measure liver scarring using a non-invasive ultrasound of the spleen (spleen stiffness measurement). It's for people with fatty liver disease (MASLD) who have advanced fibrosis (scarring) to see if this method can accurately detect the severity of liver damage.
This study compares two non-invasive ultrasound methods (EUS-SWQ and FibroScan) with liver biopsy to see how well they detect liver scarring in patients with chronic liver disease. The goal is to improve how doctors diagnose and monitor liver damage from conditions like hepatitis B and fatty liver disease.
This study is testing whether advanced imaging and other non-invasive methods can properly identify people with significant liver scarring due to metabolic liver disease or alcohol-related liver disease. It may help find better ways to track liver health without repeated needle biopsies.
This study tests a new ultrasound device that uses sound waves to measure fat in the liver without needles or surgery. It is for people with a type of fatty liver disease called MASLD or MASH, who are already getting an MRI to check their liver.
Hear when a new MAFLD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.